Medidata Solutions Thought Leaders to Lead Sessions on CRO/EDC Partnerships and Clinical Technology Standards at November Global Events
FOR IMMEDIATE RELEASE
Medidata Solutions Thought Leaders to Lead Sessions on CRO/EDC Partnerships
and Clinical Technology Standards at November Global Events
Thought Leaders to Present at Partnerships in 1st DIA China Annual Meeting,
Clinical Trials Congress and CDISC Interchange North America
NEW YORK, N.Y. – October 29, 2009 – Medidata Solutions (NASDAQ: MDSO), a leading global provider of hosted clinical development solutions, today announced that members of its executive team will deliver the following presentations at key industry events in November:
1st DIA China Annual Meeting
November 2–3, 2009, Beijing, China
Presentation: “Computerized Systems in Clinical Research: Current Quality and Data Integrity Concepts”
Speaker: Earl W. Hulihan, Senior Vice President, Regulatory Compliance
Session 2—Track 3: Globalization
Date & Time: Tuesday, November 3, 12:30 p.m. CST
8th Annual Partnerships in Clinical Trials Congress
November 4–5, 2009, Rotterdam, The Netherlands
Presentation: “Electronic Data Capture and Clinical Outsourcing: Partnering for Success”
Speaker: Graham Bunn, VP, Global CRO Partnerships
STREAM: B
Date & Time: Thursday, November 5, 12:05 p.m. CET
CDISC Interchange North America
November 11–12, 2009, Baltimore, MD
Presentation: “Using Incremental ODM Transactions in Systems Integration”
Speaker: Andrew Smith, Development Manager, R&D
Parallel Track 1. Session 6A: ODM
Date & Time: Thursday, November 12, 10:30–12:30 p.m. EST
Presentation: “Standards-Based Approach to Creating One Elegant Multi-System Solution”
Speakers: Carl Labb, Almac Clinical Technologies; Joseph Dustin, Medidata Solutions; Scott Bradley, PHT
Parallel Track 1. Session 6A: ODM
Date & Time: Thursday, November 12, 10:30–12:30 p.m. EST About 1st DIA China Annual Meeting
DIA China Annual Meeting serves as an international and neutral forum to examine important issues in global drug development and their relevance to China. Speakers for major regulatory agencies, the industry, and academia will present and lead the discussions. This multidisciplinary meeting will benefit all professionals from regulatory agencies and institutions, the biopharmaceutical industry, investigational sites, contract research organizations, and academia, who must understand how drug development impacts China as the country takes an increasingly pre-eminent place in the global arena. For more information, please visit www.diahome.org.
About Partnerships in Clinical Trials
This event focuses on strategic and practical case studies of the industry’s most successful clinical partnerships. Attendees will have access to expert analysis on the global economy, the implications for Pharma, comprehensive updates of the changing service provider market and will have the opportunity to network with industry leading professionals to solve all clinical outsourcing challenges. For more information, please visit www.ct-partnerships.com.
About CDSIC Interchange North America
CDISC is a global, open, multidisciplinary, non-profit organization that has established standards to support the acquisition, exchange, submission and archive of clinical research data and metadata. The CDISC Interchanges strive to develop and support global, platform-independent data standards that enable information system interoperability to improve medical research and related areas of healthcare. CDISC standards are vendor-neutral, platform-independent and freely available via the CDISC website. For more information, please visit www.cdisc.org.
About Medidata Solutions Worldwide
Medidata Solutions (www.mdsol.com) is a leading global provider of hosted clinical development solutions that enhance the efficiency of customers’ clinical development processes and optimize their research and development investments. Medidata products and services allow customers to achieve clinical results more efficiently and effectively by streamlining the design, planning and management of key aspects of the clinical development process, including protocol development (Medidata Designer®), investigator benchmarking and budgeting (Medidata Grants Manager™), contract research organization (CRO) benchmarking and budgeting (Medidata CRO Contractor™), and the capture, management, analysis and reporting of clinical trial data (Medidata Rave®). Medidata’s diverse customer base spans pharmaceutical, biotechnology and medical device companies, academic institutions, CROs and other research organizations, and includes more than 20 of the top 25 global pharmaceutical companies.
Contact:
Susan McCarron
Lois Paul & Partners
781.782.5767
Susan_McCarron@lpp.com